| ADR Ontology |
| ADR Term |
Adult T-cell lymphoma/leukaemia |
| ADR ID |
BADD_A06873 |
| ADR Hierarchy |
|
| Description |
Aggressive T-Cell malignancy with adult onset, caused by HUMAN T-LYMPHOTROPIC VIRUS 1. It is endemic in Japan, the Caribbean basin, Southeastern United States, Hawaii, and parts of Central and South America and sub-Saharan Africa. [MeSH] |
| MedDRA Code |
10001413 |
| MeSH ID |
D015459
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Adult T-cell leukemia-lymphoma | Adult T-cell lymphoma/leukaemia | Adult T-cell lymphoma/leukaemia NOS | Diffuse large cell lymphoma (Adult T-cell lymphoma/leukaemia) (Working Formulation) | Diffuse mixed small and large cell lymphoma (Adult T-cell lymphoma/leukaemia) (Working Formulation) | Diffuse small cleaved cell lymphoma (Adult T-cell lymphoma/leukaemia) (Working Formulation) | Pleomorphic medium sized and large T-cell HTLV1 lymphoma (Kiel Classification) | Pleomorphic small T-cell HTLV1 lymphoma (Kiel Classification) | T-immunoblastic sarcoma (Adult T-cell lymphoma/leukaemia) (Lukes-Collins Classification) | Adult T-cell lymphoma/leukemia | T-immunoblastic sarcoma (Adult T-cell lymphoma/leukemia) (Lukes-Collins Classification) | Diffuse large cell lymphoma (Adult T-cell lymphoma/leukemia) (Working Formulation) | Diffuse mixed small and large cell lymphoma (Adult T-cell lymphoma/leukemia) (Working Formulation) | Diffuse small cleaved cell lymphoma (Adult T-cell lymphoma/leukemia) (Working Formulation) | Leukemia-Lymphoma, Adult T-Cell | Adult T-Cell Leukemia-Lymphoma | Adult T-Cell Leukemia-Lymphomas | Leukemia-Lymphomas, Adult T-Cell | T-Cell Leukemia-Lymphomas, Adult | HTLV I Associated T Cell Leukemia Lymphoma | HTLV-Associated Leukemia-Lymphoma | HTLV Associated Leukemia Lymphoma | HTLV-Associated Leukemia-Lymphomas | Leukemia-Lymphoma, HTLV-Associated | Leukemia-Lymphomas, HTLV-Associated | HTLV-I-Associated T-Cell Leukemia-Lymphoma | HTLV-I-Associated T-Cell Leukemia-Lymphomas | Leukemia-Lymphoma, HTLV-I-Associated T-Cell | Leukemia-Lymphomas, HTLV-I-Associated T-Cell | T-Cell Leukemia-Lymphomas, HTLV-I-Associated | Human T Lymphotropic Virus Associated Leukemia Lymphoma | Human T Lymphotropic Virus-Associated Leukemia-Lymphoma | Human T-Cell Leukemia-Lymphoma | Human T Cell Leukemia Lymphoma | Human T-Cell Leukemia-Lymphomas | Leukemia-Lymphoma, Human T-Cell | Leukemia-Lymphomas, Human T-Cell | T-Cell Leukemia-Lymphoma, Human | T-Cell Leukemia-Lymphomas, Human | Leukemia Lymphoma, Adult T Cell | Leukemia Lymphoma, T Cell, Acute, HTLV I Associated | Leukemia, Adult T-Cell | Adult T-Cell Leukemia | Adult T-Cell Leukemias | Leukemia, Adult T Cell | Leukemias, Adult T-Cell | T-Cell Leukemias, Adult | Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated | T Cell Leukemia Lymphoma, HTLV I Associated | T Cell Leukemia, Adult | T-Cell Leukemia, Adult | T-Cell Leukemia-Lymphoma, Adult | T Cell Leukemia Lymphoma, Adult | T-Cell Leukemia-Lymphoma, HTLV-I-Associated | ATLL |
|
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01253 | Lenalidomide | 0.019048% | | | BADD_D02105 | Tacrolimus | 0.000594% | |
| The 1th Page 1
Total 1 Pages
|
|
